$FLD
FTAC Emerald Acquisition Corp

2024 Q3 Form 10-Q Financial Statement

#000121390024096828 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $680.0K
YoY Change 52.54%
Operating Profit -$801.4K -$683.6K
YoY Change 17.24% 53.34%
Interest Expense $3.280M
YoY Change 189.5%
% of Operating Profit
Other Income/Expense, Net $540.7K -$710.0K
YoY Change -176.16%
Pretax Income -$260.7K $1.887M
YoY Change -113.82% 174.56%
Income Tax $136.3K $680.2K
% Of Pretax Income 36.05%
Net Earnings -$397.0K $1.207M
YoY Change -132.9% 158.09%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.04
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change -100.0%
Cash & Equivalents $20.44K $25.62K
Short-Term Investments
Other Short-Term Assets $100.0K
YoY Change -67.78%
Inventory
Prepaid Expenses $114.3K
Receivables
Other Receivables
Total Short-Term Assets $159.9K $109.1K
YoY Change 46.59% -84.45%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $164.0M
YoY Change -35.03%
Other Assets
YoY Change
Total Long-Term Assets $52.00M $165.2M
YoY Change -68.52% -34.88%
TOTAL ASSETS
Total Short-Term Assets $159.9K $109.1K
Total Long-Term Assets $52.00M $165.2M
Total Assets $52.16M $165.3M
YoY Change -68.44% -35.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K
YoY Change 229.71%
Accrued Expenses $1.000M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.500M
YoY Change 9018.54%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.407M $2.936M
YoY Change 118.18% 801.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $9.900M
YoY Change 0.41%
Total Long-Term Liabilities $9.900M
YoY Change 0.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.407M $2.936M
Total Long-Term Liabilities $9.900M
Total Liabilities $7.562M $12.80M
YoY Change -40.9% 25.63%
SHAREHOLDERS EQUITY
Retained Earnings -$13.90M -$11.54M
YoY Change 20.44% 43.12%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.402M -$11.54M
YoY Change
Total Liabilities & Shareholders Equity $52.16M $165.3M
YoY Change -68.44% -35.01%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$397.0K $1.207M
YoY Change -132.9% 158.09%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.140M
YoY Change 198.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $97.58M
YoY Change 101662.44%
Cash From Investing Activities $97.58M
YoY Change 101662.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -96.57M
YoY Change
NET CHANGE
Cash From Operating Activities -1.140M
Cash From Investing Activities 97.58M
Cash From Financing Activities -96.57M
Net Change In Cash -130.0K
YoY Change -54.51%
FREE CASH FLOW
Cash From Operating Activities -$1.140M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
CY2024Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41168
dei Entity Registrant Name
EntityRegistrantName
FTAC EMERALD ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2170416
dei Entity Address Address Line1
EntityAddressAddressLine1
2929 Arch Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1703
dei Entity Address City Or Town
EntityAddressCityOrTown
Philadelphia
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19104
dei City Area Code
CityAreaCode
(215)
dei Local Phone Number
LocalPhoneNumber
701-9555
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20439 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29844 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
114312 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
192712 usd
CY2024Q3 emld Prepaid Income Taxes Current
PrepaidIncomeTaxesCurrent
25134 usd
CY2023Q4 emld Prepaid Income Taxes Current
PrepaidIncomeTaxesCurrent
83503 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
159885 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
306059 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
51996271 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
165653149 usd
CY2024Q3 us-gaap Assets
Assets
52156156 usd
CY2023Q4 us-gaap Assets
Assets
165959208 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
289103 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
114659 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2122813 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
967916 usd
CY2024Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
438501 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6406868 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3394026 usd
CY2024Q3 emld Deferred Advisory Fee
DeferredAdvisoryFee
1155000 usd
CY2023Q4 emld Deferred Advisory Fee
DeferredAdvisoryFee
1155000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
7561868 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4549026 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6493705 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6984216 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13896647 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11296875 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-7401983 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4311700 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52156156 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
165959208 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
801420 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
683551 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2154179 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2250994 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-801420 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-683551 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2154179 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2250994 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
668748 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3278712 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2353695 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
9027924 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
128012 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
323197 usd
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
708400 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
838825 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
708400 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
540736 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2570312 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1191673 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8319524 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-260684 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1886761 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-962506 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6068530 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
136342 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
680171 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
482369 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1866506 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-397026 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1206590 usd
us-gaap Net Income Loss
NetIncomeLoss
-1444875 usd
us-gaap Net Income Loss
NetIncomeLoss
4202024 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-4311700 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
792603 usd
CY2024Q1 emld Adjustments To Additional Paid In Capital Contribution From The Sponsor
AdjustmentsToAdditionalPaidInCapitalContributionFromTheSponsor
838825 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
276625 usd
CY2024Q1 emld Adjustmentto Accumulated Deficit Excise Taxes On Stock Redemption
AdjustmenttoAccumulatedDeficitExciseTaxesOnStockRedemption
1154897 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-824042 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5967792 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
453677 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
158071 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-223807 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-6487205 usd
CY2024Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
517752 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-397026 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-7401983 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8500817 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2048355 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1267859 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9281313 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2372121 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1727575 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-9925859 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2558741 usd
CY2023Q3 emld Adjustmentto Accumulated Deficit Excise Taxes On Stock Redemption
AdjustmenttoAccumulatedDeficitExciseTaxesOnStockRedemption
967916 usd
CY2023Q3 emld Adjustments To Additional Paid In Capital Contribution For Nonredemption Agreements
AdjustmentsToAdditionalPaidInCapitalContributionForNonredemptionAgreements
-708400 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1206590 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-11537526 usd
us-gaap Net Income Loss
NetIncomeLoss
-1444875 usd
us-gaap Net Income Loss
NetIncomeLoss
4202024 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2353695 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
9027924 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
838825 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
708400 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
323197 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-78400 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-152849 usd
emld Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
-58369 usd
emld Increase Decrease In Prepaid Income Taxes
IncreaseDecreaseInPrepaidIncomeTaxes
51084 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
270000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
174444 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
335969 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-359410 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2055335 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4039176 usd
emld Proceedsfrom Cash Withdrawn From Trust Account In Connection With Redemption
ProceedsfromCashWithdrawnFromTrustAccountInConnectionWithRedemption
115489643 usd
emld Proceedsfrom Cash Withdrawn From Trust Account In Connection With Redemption
ProceedsfromCashWithdrawnFromTrustAccountInConnectionWithRedemption
96791644 usd
emld Proceeds From Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
ProceedsFromCashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
520930 usd
emld Proceeds From Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes
ProceedsFromCashWithdrawnFromTrustAccountToPayFranchiseAndIncomeTaxes
2492046 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
116010573 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
99283690 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
550000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
975000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1500000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
115489643 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
96791644 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-113964643 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-95291644 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9405 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-47130 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29844 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72753 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20439 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25623 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
424000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
2277000 usd
emld Excise Tax On Stock Redemption
ExciseTaxOnStockRedemption
1154897 usd
emld Excise Tax On Stock Redemption
ExciseTaxOnStockRedemption
967916 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1. ORGANIZATION AND BUSINESS OPERATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FTAC Emerald Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on February 19, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company may pursue an initial Business Combination target in any business or industry.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, the Company had not commenced any operations. All activity for the period from February 19, 2021 (inception) through September 30, 2024 relates to the Company’s formation, the Public Offering (the “Public Offering” or “IPO”), and efforts in identifying a target to consummate an initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Public Offering placed in the Trust Account.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s Sponsors are Emerald ESG Sponsor, LLC, a Delaware limited liability company, and Emerald ESG Advisors, LLC, a Delaware limited liability company (collectively, the “Sponsor”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registration statement for the Company’s Public Offering was declared effective on December 15, 2021 (the “Effective Date”). On December 20, 2021, the Company consummated its Public Offering of 22,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “public shares”) at $10.00 per Unit, which is discussed in Note 3, and the sale of 890,000 placement units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor, which is discussed in Note 4 (“Private Placement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The underwriter of the Company’s IPO subsequently provided notice of its election to partially exercise its over-allotment option, and the closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on January 14, 2022. A total aggregate issuance by the Company of 2,869,342 Over-Allotment Option Units at a price of $10.00 per Over-Allotment Option Unit resulted in total gross proceeds of $28,693,420 to the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simultaneously with the issuance and sale of the Over-Allotment Option Units, the Company consummated the private sale of an additional 86,081 Private Placement Units (the “Additional Private Placement Units”) at a price of $10.00 per Additional Private Placement Unit to the Sponsor, generating gross proceeds of $860,810.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transaction costs related to the IPO and over-allotment amounted to $14,181,568, consisting of $4,973,868 of underwriting commissions, $8,704,270 in deferred underwriting fees, and $503,430 of other offering costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the Company’s signing a definitive agreement in connection with the initial Business Combination. However, the Company will only complete an initial Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Following the closing of the Public Offering, the partial exercise of the over-allotment option, and the sale of the Private Placement Units, a total of $251,180,354 ($10.10 per Unit) was initially placed in a Trust Account (“Trust Account”). The proceeds are invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except for any interest income released to the Company to pay franchise and income taxes and up to $100,000 of interest to pay dissolution expenses, <span style="-sec-ix-hidden: hidden-fact-93">none</span> of the funds held in trust will be released from the Trust Account until the earlier of (i) the consummation of the initial Business Combination; (ii) the redemption of the public shares if the Company is unable to consummate a Business Combination by December 20, 2024 (the “Completion Window”); or (iii) the redemption of any public shares properly tendered in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the public shares in connection with an initial Business Combination or to redeem 100% of the public shares if the Company has not consummated the initial Business Combination within the Completion Window, or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the public stockholders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 19, 2023, the Company held a special meeting of its stockholders (the “Meeting”) at which the Company’s stockholders approved (A) an amendment (the “Charter Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation to extend the date by which the Company has to consummate its initial business combination from September 20, 2023 to January 19, 2024 (or such earlier date as determined by the Company’s Board of Directors); and (B) an amendment (the “Trust Amendment”) to the Company’s Investment Management Trust Agreement dated December 15, 2021, with Continental Stock Transfer &amp; Trust Company, as trustee (the “Trust Agreement”), to allow the trustee to liquidate the Trust Account established in connection with the IPO at such time as may be determined by the Company as set forth in the Charter Amendment. In connection with the Meeting the holders of 9,239,192 shares of redeemable Class A common stock exercised their right to redeem their shares for cash at a redemption price of approximately $10.4762 per share, for an aggregate redemption amount of approximately $96,791,644. Following the redemptions, 15,630,150 shares of redeemable Class A common stock remained outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Between September 7 and 15, 2023, the Company entered into non-redemption agreements with unaffiliated third parties in exchange for each such party agreeing not to redeem public shares in connection with the Meeting. In exchange for the foregoing commitments not to redeem public shares, the Company has agreed to issue or cause to be issued an aggregate of 1,610,000 shares of Class A common stock at the time of the Company’s initial business combination (“Investor Shares”).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 19, 2024, the Company held a special meeting of its stockholders (the “January Meeting”) at which the Company’s stockholders approved (A) an amendment (the “January Charter Amendment”) to the Company’s Second Amended and Restated Certificate of Incorporation to extend the date by which the Company has to consummate its initial business combination from January 19, 2024 to December 20, 2024 (or such earlier date as determined by the Company’s Board of Directors); and (B) an amendment (the “January Trust Amendment”) to the Trust Agreement to allow the trustee to liquidate the Trust Account established in connection with the IPO at such time as may be determined by the Company as set forth in the January Charter Amendment. In connection with the January Meeting the holders of 10,872,266 shares of redeemable Class A common stock exercised their right to redeem their shares for cash at a redemption price of approximately $10.6224 per share, for an aggregate redemption amount of approximately $115,489,643. Following the redemptions, 4,757,884 shares of redeemable Class A common stock remain outstanding.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Between January 9 and 17, 2024, the Company entered into non-redemption agreements with unaffiliated third parties in exchange for each such party agreeing not to redeem public shares in connection with the January Meeting. In exchange for the foregoing commitments not to redeem public shares, the Company has agreed to issue or cause to be issued an aggregate of 1,112,500 Investor Shares. In addition, the Company has agreed that it will not utilize any funds from the Trust Account to pay any potential excise taxes that may become due pursuant to the IR Act (as defined below) upon a redemption of public shares, including in connection with the January Charter Amendment, an initial business combination or liquidation of the Company.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 28, 2024, the Company’s securities were transferred to the Nasdaq Capital Market at the opening of business.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 24, 2024, the Company and Fold, Inc. (“Fold”) announced that they have entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, EMLD Merger Sub Inc., a wholly-owned subsidiary of the Company (“Merger Sub”), and Fold, pursuant to which, among other things, Merger Sub will be merged with and into Fold with Fold surviving the merger as a wholly-owned subsidiary of the Company (the “Merger” and, together with the other transactions contemplated by the Merger Agreement, the “Transactions”) (Note 6).</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Liquidity and Going Concern</i></b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024, the Company had $20,439 in cash and a working capital deficit of $6,159,733. Prior to the completion of the Company’s IPO, the Company’s liquidity needs had been satisfied through a capital contribution from the Sponsor of $25,000 and a loan to the Company of up to $300,000 by the Company’s Sponsor under an unsecured promissory note. The outstanding balance under the promissory note of $105,260 was repaid on December 27, 2021, and the promissory note was terminated. </p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes the initial Business Combination, the Company expects to repay such loaned amounts out of the proceeds of the Trust Account released to it. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. As of September 30, 2024 and December 31, 2023, $3,000,000 and $2,025,000 of Working Capital Loans were outstanding, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 13, 2023, the Sponsor agreed to loan the Company up to $1,500,000 (the “Promissory Note”). The Promissory Note is non-interest bearing and all outstanding amounts under the Promissory Note will be due on the date on which the Company consummates a Business Combination. If the Company does not consummate a Business Combination, the Company may use a portion of any funds held outside the Trust Account to repay the Promissory Note; however, no proceeds from the Trust Account may be used for such repayment. If such funds are insufficient to repay the Promissory Note, the unpaid amounts would be forgiven. No portion of the amounts outstanding under the Promissory Note may be converted into units at a price of $10.00 per unit, which would have been permissible as described in the prospectus filed in connection with the IPO. On October 16, 2023, the Company and the Lender amended the Promissory Note to increase the aggregate principal amount of the Promissory Note from $1,500,000 to $3,000,000. All other material terms of the Promissory Note remain in full force and effect. As of September 30, 2024 and December 31, 2023, there was $3,000,000 and $2,025,000 outstanding under the Promissory Note, respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will need to raise additional capital through loans or additional investments from the Initial Stockholders or its officers, directors or their affiliates. The Initial Stockholders and the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until December 20, 2024 to consummate a Business Combination. It is uncertain whether the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. Management intends to consummate a Business Combination prior to December 20, 2024. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after December 20, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Subscription Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On January 3, 2024, the Company entered into a subscription agreement with Polar Multi-Strategy Master Fund (“Polar”), Emerald ESG Sponsor, LLC (“ESG Sponsor”), Emerald ESG Advisors, LLC (“ESG Advisors”) and Emerald ESG Funding, LLC (“ESG Funding” and collectively with ESG Sponsor and ESG Advisors, the “Sponsors”), to cover working capital requirements of the Company and costs related to a possible extension of the Company’s trust liquidation date (the “Subscription Agreement”). Pursuant to the terms and subject to the conditions of the Subscription Agreement, Polar agreed to contribute up to $550,000 to ESG Funding (the “Capital Contribution”). An initial capital call of $350,000 took place within five (5) business days of the signing of the Subscription Agreement, and a second capital call of $200,000 took place on April 2, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Capital Contribution shall be repaid to Polar by ESG Funding upon the Company’s closing of an initial business combination (the “Closing”). In consideration of the Capital Contribution, the Company has agreed to issue, or to cause the surviving entity following the Closing (the “Surviving Company”) to issue, 1.0 share of common stock of the Surviving Company (“Common Stock”) for each dollar of the Capital Contribution funded as of or prior to the Closing, which shares shall be subject to no transfer restrictions or any other lock-up provisions, earn outs, or other contingencies and shall be registered as part of any registration statement to be filed in connection with the Closing or, if no such registration statement is filed in connection with the Closing, pursuant to the first registration statement to be filed by the Company or the Surviving Company following the Closing. The Capital Contribution is non-interest bearing and shall be repaid by ESG Funding (upon receipt of funds from the Company) to, and at the election of, Polar (i) in Common Stock, at a rate of 1.0 share of Common Stock for each ten dollars ($10.00) of the Capital Contribution funded as of the Closing or (ii) in cash.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Company liquidates without consummating an initial business combination, any amounts remaining in the Sponsors’ or the Company’s cash accounts, not including the Company’s Trust Account, following repayment of all liabilities and wind-down expenses, will be paid promptly to Polar, up to the amount of the Capital Contribution funded. Upon certain events of default under the Subscription Agreement, the Company shall issue to Polar 0.1 shares of Common Stock (“Default Shares”) for each dollar of the Capital Contribution funded as of the date of such default, and for each month thereafter until such default is cured, subject to certain limitations provided for therein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024 and December 31, 2023, $550,000 and <span style="-sec-ix-hidden: hidden-fact-94">$0</span> was outstanding on the promissory note, gross of the discount, under the subscription agreement, respectively.</p>
CY2024Q3 emld Transaction Costs
TransactionCosts
14181568 usd
emld Underwriting Commissions
UnderwritingCommissions
4973868 usd
emld Deferred Underwriting Fees
DeferredUnderwritingFees
8704270 usd
emld Other Offering Costs
OtherOfferingCosts
503430 usd
emld Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000 usd
CY2024Q3 emld Percentage Of Public Shares Redeem
PercentageOfPublicSharesRedeem
1 pure
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
115489643 usd
CY2024Q3 us-gaap Cash
Cash
20439 usd
CY2024Q3 emld Working Capital
workingCapital
6159733 usd
CY2024Q3 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
300000 usd
CY2021Q4 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
105260 usd
emld Working Capital Loan Outstanding
WorkingCapitalLoanOutstanding
3000000 usd
CY2023 emld Working Capital Loan Outstanding
WorkingCapitalLoanOutstanding
2025000 usd
CY2024Q2 us-gaap Capital Units
CapitalUnits
200000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
550000 usd
emld Emerging Growth Company Status
EmergingGrowthCompanyStatus
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Emerging Growth Company</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q3 us-gaap Cash
Cash
20439 usd
CY2023Q4 us-gaap Cash
Cash
29844 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
51996271 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
165653149 usd
emld Investment Maximum Maturity Term
InvestmentMaximumMaturityTerm
P185D
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.523 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.5012 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.2621 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.2754 pure
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition.</p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
CY2022Q3 emld Excise Tax Rate
ExciseTaxRate
0.01 pure
CY2022Q3 emld Fair Market Value Percentages
FairMarketValuePercentages
0.01 pure
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
9239192 shares
CY2023Q3 us-gaap Payable Common Stock Redeemed
PayableCommonStockRedeemed
96791644 usd
CY2024Q1 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
10872266 shares
CY2024Q1 us-gaap Payable Common Stock Redeemed
PayableCommonStockRedeemed
115489643 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2122813 usd
CY2023Q3 emld Percentageof Shares Redeemed For Excise Tax Liability
PercentageofSharesRedeemedForExciseTaxLiability
0.01 pure
CY2024Q1 emld Percentageof Shares Redeemed For Excise Tax Liability
PercentageofSharesRedeemedForExciseTaxLiability
0.01 pure
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
248693420 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
8264360 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13734146 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
27119341 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
253814255 usd
CY2023 us-gaap Redemption Premium
RedemptionPremium
96791644 usd
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
8699271 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
165721882 usd
us-gaap Redemption Premium
RedemptionPremium
115489643 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1764032 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
51996271 usd
CY2021Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1.1014-for-1.0
CY2021Q4 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
0.9955-for-1.0
emld Founder Share Percentage
FounderSharePercentage
1 pure
us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares (i) with respect to 25% of such shares, until consummation of the initial Business Combination, (ii) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $12.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, (iii) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $13.50 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, and (iv) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $15.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination.
us-gaap Payments For Rent
PaymentsForRent
30000 usd
CY2024Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
90000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
270000 usd
CY2023Q3 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
90000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
270000 usd
emld Outstanding Public Warrants Percentage
OutstandingPublicWarrantsPercentage
0.50 pure
us-gaap Underwriting Expense Ratio
UnderwritingExpenseRatio
0.02 pure
emld Deferred Underwriting Discount
DeferredUnderwritingDiscount
0.035 pure
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
8704270 usd
CY2023Q4 emld Deferred Underwriters Discount
DeferredUnderwritersDiscount
8704270 usd
emld Aggregate Percentage Underwritting Expenses
AggregatePercentageUnderwrittingExpenses
0.003 pure
emld Advisory Fee Percentage
advisoryFeePercentage
0.00525 pure
us-gaap Investment Company Expense After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement
1155000 usd
CY2023 us-gaap Payments For Fees
PaymentsForFees
1155000 usd
emld Aggregate Share
AggregateShare
1610000 shares
emld Aggregate Fair Value Of Investor Shares
AggregateFairValueOfInvestorShares
1610000 shares
emld Non Redeeming Shareholders Par Value
NonRedeemingShareholdersParValue
0.44
CY2024Q1 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
350000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
111499 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
438501 usd
us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
365000000 usd
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
90000 usd
emld Aggregated Consideration Percentage
AggregatedConsiderationPercentage
0.20 pure
emld Bitcoin Amount
BitcoinAmount
54750000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
emld Description Of Exercise Price And Number Of Shares Of Common Stock
DescriptionOfExercisePriceAndNumberOfSharesOfCommonStock
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
CY2024Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
emld Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days
ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
P30D
emld Initial Value
InitialValue
550000 usd
emld Discount On Note Payable Net Of Amortization
DiscountOnNotePayableNetOfAmortization
111499 usd
CY2024Q3 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
438501 usd
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2024Q3 emld Funds Held In Trust
FundsHeldInTrust
usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001889123

Files In Submission

Name View Source Status
0001213900-24-096828-index-headers.html Edgar Link pending
0001213900-24-096828-index.html Edgar Link pending
0001213900-24-096828.txt Edgar Link pending
0001213900-24-096828-xbrl.zip Edgar Link pending
ea0219893-10q_ftac.htm Edgar Link pending
ea021989301ex31-1_ftac.htm Edgar Link pending
ea021989301ex31-2_ftac.htm Edgar Link pending
ea021989301ex32-1_ftac.htm Edgar Link pending
ea021989301ex32-2_ftac.htm Edgar Link pending
emld-20240930.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
emld-20240930_cal.xml Edgar Link unprocessable
emld-20240930_def.xml Edgar Link unprocessable
emld-20240930_lab.xml Edgar Link unprocessable
emld-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0219893-10q_ftac_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending